third annual pathology educational...
TRANSCRIPT
Third Annual Pathology
Educational Symposium
November 2 - 4, 2015
Turner Auditorium 720 Rutland Avenue
Baltimore, MD 21205
Sponsored by the Department of Pathology
2
Description: This Continuing Education event is intended for all employees of the Johns Hopkins Medicine Department of Pathology and Johns Hopkins Medical Laboratories.
Cost: Free for all Pathology and Johns Hopkins Medical Laboratory employees
Preregistration is encouraged (and required to receive lunch):
Preregistration is open September 14 - October 15, 2015.
Preregistration can be done through the ActivTracker website for all JHMI staff:
http://pathology.jhu.edu/department/training/symposium.
cfm See your Supervisor for approval to attend during your normal working hours.
JHM I.D. badge is required for electronic attendance tracking. Registration: Turner Lower Concourse. Register only once on the first day of attendance to pick up materials. Breaks: Light refreshments will be available between sessions in the Lower Turner Concourse.
Lunch: Will be provided for attendees who have preregistered for lunch and attend at least one session that day. (Lunch may not be available for those not preregistered for lunch.) Lunch pick-up is in the Turner Lower Concourse: Monday, November 2 12:15-12:45p Tuesday, November 3 12:00-12:45p Wednesday, November 4 12:00-12:45p
3
New Poster Session: Poster presentations will be available for the duration of the Symposium and will allow attendees to receive additional P.A.C.E.® Continuing Education credit. Questions must be answered for a minimum of five posters and a minimum passing score of 80% must be achieved. No partial credits can be awarded, and answers must be turned in by November 13, 2015. Examples:
Questions answered for 5 posters with 80% receive 1.0 CEU. Questions answered for 10 posters with 80% receive 2.0 CEU.
Preregistration is not required for Poster Session. Attendance Documentation & Certificate:
1. Swipe I.D. badge / sign in for all sessions attending. (NO CE credit will be available for those arriving more than 10 minutes after
the start time.) 2. Record Session Code on Attendance Documentation
form (provided at the end of the session). 3. Turn in completed Attendance Documentation form at
registration desk or email to Symposium Committee. Both sign-in / swipe-in & Attendance Documentation form are required to receive your PACE® certificate.
4. Certificate and evaluations will be emailed to attendees within three weeks of the Symposium.
Volunteer Opportunities: If you would like to help with the
Symposium, please register at http://vols.pt/eb8ujK to sign up. Volunteers are needed in several areas:
Registration Desk: Hand out materials & give directions to rooms. Moderator: Introduce session and speaker. Room Lead: Assist attendees in swiping/signing in for their session.
Lunch: Assist attendees with obtaining lunch.
Johns Hopkins Medicine is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
4
Monday, November 2, 2015
8:00a-3:30p: Registration (Turner Concourse)
Opening Session & Pathology Grand Rounds 8:30a-9:30a Room: Turner Auditorium
Taking Quality to the Next Level Course # 612-202-15 / 1.0 credit hours
Peter J. Pronovost, MD, PhD, FCCM
The C. Michael and S. Anne Armstrong Professor for Patient Safety and Quality Johns Hopkins Medicine Senior Vice President for Patient Safety and Quality, Director of the Armstrong Institute for Patient Safety and Quality Professor, Anesthesiology, Critical Care Medicine, Surgery, Nursing, Bloomberg School of Public Health, Carey Business School
Level of Instruction: Basic Category: General Target Audience: All are welcome Description: Dr. Peter Pronovost is an anesthesiologist and critical care physician who is dedicated to finding ways to improve patient safety. He developed a method to reduce central line catheter infections that could be fatal. Time Magazine named Dr. Pronovost as one of the world’s 100 most influential people for his work in patient safety. Please join us for a kick-off to our Third Annual Pathology Symposium with a presentation on how Johns Hopkins is leading efforts to improve healthcare quality and safety. Objectives: At the completion of the presentation, the audience will be able to:
Identify at least one way to improve patient safety Explain how to improve the quality of our work
5
Monday, November 2, 2015
10:00a–11:00a Room: TBA
Update on Hepatitis C: The End of the Beginning Course # 612-203-15 / 1.0 credit hours
Alexandra Valsamakis, MD, PhD Associate Professor of Pathology Johns Hopkins University School of Medicine Director, Clinical Virology and Molecular Microbiology Laboratories Johns Hopkins Hospital
Level of Instruction: Intermediate Category: Microbiology Target Audience: All are welcome Description: This session will describe the current status of screening to identify individuals infected with hepatitis C virus (HCV), the drugs currently used to treat chronic hepatitis C, and useful diagnostic tests in detection and management of HCV infection.
Objectives: At the completion of the presentation, the audience will be able to:
Summarize new screening recommendations for the identification of individuals with chronic hepatitis C
Identify and describe the new drugs used for treatment of chronic hepatitis C
List which diagnostic tests are useful in therapeutic management with new drug regimens for chronic hepatitis C
6
Monday, November 2, 2015
10:00a–11:00a Room: TBA
Snakes, Snake Hunting, and the Pathophysiology of a
Snakebite
Course # 612-215-15 / 1.0 credit hours
J. Judd Fite, MD, MBA Resident Physician, PGY3 Department of Pathology Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: General, Hematology Target Audience: All are welcome
Description: This is a unique and fun presentation that uses photos and field experiences to portray the beauty and wonder of snakes. Dr. Fite will discuss the pathophysiology of snake bites and how isolated compounds from snake venom have played a significant role in medicine and the specialty of pathology. Objectives: At the completion of the presentation, the audience will be able to:
Explain how snake venom is a complex mixture of compounds unique to a species with specific functions
Appreciate how the isolation of compounds has had a significant impact on the practice of medicine from hematology to the fight against cancer
Explain the pathophysiology of snake envenomation
7
Monday, November 2, 2015
11:15a-12:15p Room: TBA
Urine for a Good Talk: Why Urinary Tract
Cytopathology Is Popular Once Again
Course # 612-216-15 / 1.0 credit hours
Christopher J. VandenBussche, MD, PhD Assistant Professor of Pathology Division of Cytopathology Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Cytopathology Target Audience: All are welcome
Description: The microscopic examination of urinary tract (UT) specimens has been used for decades to help evaluate kidney diseases and detect UT cancers (such as bladder cancer). Because UT cancer has become one of the most expensive cancers to the United States health care system, interest has grown in how the microscopic examination of urine, a relatively inexpensive test, can be improved to better manage patients at risk for UT cancer. This session will examine the history and concepts behind UT cytopathology, recent new findings which are altering the practice of UT cytopathology, and future challenges facing this field. Objectives: At the completion of the presentation, the audience will be able to:
List the major cytomorphological findings in the microscopic examination of UT specimens and describe their clinical significance
Identify the major controversies in the field of UT cytopathology and how recent studies have helped address these controversies
Describe the limitations of UT cytopathology and how new clinical tests may help overcome these limitations
8
Monday, November 2, 2015
11:15a-12:15p Room: TBA
What Does the Culture of Safety Mean to
Laboratorians?
Course # 612-225-15 / 1.0 credit hours
Meredith Hurston, MHA, MLS(ASCP) Quality Assurance Specialist, CQI Office Department of Pathology The Johns Hopkins Hospital
Linda Gluck, MT(ASCP), MS Quality Assurance Specialist, Clinical Microbiology Division Department of Pathology The Johns Hopkins Hospital
Lisa Shifflett, BB(ASCP)CM
Quality Assurance Specialist, Transfusion Medicine Division Department of Pathology The Johns Hopkins Hospital
Level of Instruction: Basic Category: Quality Assurance/Safety Target Audience: All are welcome
Description: This presentation will provide an overview of the culture of safety in Pathology as determined by the Spring 2015 Safety Culture survey administration. What is our perception of safety in our work setting? Who monitors the safety and quality for the Department of Pathology? When we enter a PSN (Patient Safety Net) event, does it go into a “black hole”? What is the process for investigation and review of PSNs? How are our Department's quality and safety indicators reported throughout the Johns Hopkins Medicine?
Objectives: At the completion of the presentation, the audience will be able to:
Describe the current perception of the culture of safety in Pathology
Explain how PSNs are investigated and reviewed
Recognize their role in the culture of safety and the value in reporting potential adverse events
Discuss the current fiscal year indicators being monitored by the Hospital Quality Program
9
Monday, November 2, 2015 1:00p-2:00p Room: TBA
Weird Micro III: The Animal Planet
Course # 612-209-15 / 1.0 credit hours
Paula C. Mister, MS, MT, SM(ASCP)CM Educational Coordinator, Clinical Microbiology Division Department of Pathology The Johns Hopkins Hospital
Level of Instruction: Intermediate Category: Microbiology Target Audience: All are welcome (especially technologists, leads, and physicians)
Description: The third installment of a fun and interactive session in which unusual and interesting cases from the Johns Hopkins Clinical Microbiology Laboratory will be presented. The audience will assist in making the diagnosis from the clinical information and clues provided. This session will focus on pathogens, in particular from animal sources. Each case will be followed by a brief discussion on both new and old methods for identification of these pathogens. Objectives: At the completion of the presentation, the audience will be able to:
Integrate information from patient history, symptoms, lab results, and additional clues provided to postulate microbiologic pathogens from the cases presented
Develop an increased awareness of unusual animal pathogens, or pathogens from unusual sources in the clinical laboratory
Describe laboratory methods that can detect these pathogens in an accurate and timely way
10
Monday, November 2, 2015
1:00p-2:00p Room: TBA
Sickle Cell Disease
Course # 612-229-15 / 1.0 credit hours
Sophie Lanzkron, MD, MHS Director, Sickle Cell Center for Adults at Johns Hopkins Associate Professor of Medicine and Oncology Johns Hopkins Medicine
Level of Instruction: Intermediate Category: Hematology / Blood Bank Target Audience: All are welcome
Description: This session will discuss the basic pathophysiology of sickle cell disease, diagnostic testing, and those tests used to follow disease. In addition, complications and therapies will also be described. Objectives: At the completion of the presentation, the audience will be able to:
Describe the pathophysiology of sickle cell disease
Explain the role of hematology testing to diagnose and follow sickle cell disease
Identify the role of the Blood Bank in the treatment of sickle cell disease
11
Monday, November 2, 2015
1:00p-2:00p Room: TBA
The Magic of Auto-SMILE
Course # 612-206-15 / 1.0 credit hours
Michael Reach, PhD IT Contractor Pathology Informatics Johns Hopkins Hospital
Aidel Weisberg, BA IT Specialist Pathology Informatics Johns Hopkins Hospital
Rod Julius, BA Programmer Analyst Pathology Informatics Johns Hopkins Medicine
Level of Instruction: Basic Category: Computer/IT, Quality Assurance Target Audience: All are welcome
Description: Demonstration of a new web-based system which uses automation to simplify and standardize workflow and output. The systems development team includes staff members from Pathology Data Systems, the Patient Safety Monitoring in International Laboratories (SMILE) group, and consultants. The system is currently in use by the SMILE contract group to monitor over 150 international laboratories and is in early development for use by JHH Continuous Quality Improvement Programs office. Objectives: At the completion of the presentation, the audience will be able to:
Explain "What is Auto-SMILE?"
List some of the challenges and benefits involved in automation of quality assurance workflow
Execute a basic-level query on SMILE data
12
Monday, November 2, 2015
2:15p-3:15p Room: TBA
When Good Devices Go Bad! Managing Technology
Malfunctions Course # 612-228-15 / 1.0 credit hours
Jeffrey Natterman, RRT, MA, JD Risk Manager, Johns Hopkins Hospital Associate Senior Counsel, Johns Hopkins Health System Johns Hopkins Medicine
Level of Instruction: Basic Category: Quality Assurance/Regulatory Target Audience: All are welcome Description: Healthcare organization staff are expected to apply highly sophisticated technology to treat patients directly or indirectly. Maintenance and training, including regular competency checking and proper data gathering, are critically important to ensure that patients are appropriately treated. Equally important is managing technology that is either poorly designed, malfunctions, or is recalled. This lecture material will give the audience an overview of issues facing technology managers including the regulatory framework for reporting and responding to device failures. Specifically, information will include the FDA regulatory requirements for reporting technologies that fail, the burden on hospitals and manufacturers, recall management, in addition to human factor related issues the healthcare team faces daily. Objectives: At the completion of the presentation, the audience will be able to:
Explain the legal reporting and management requirements for technology failure
Apply concepts related to proper training, human factors, and other interface issues for healthcare workers who use devices in the workplace
13
Monday, November 2, 2015
2:15p-3:15p Room: TBA
Difficult or Depressed? Recognizing Depression
Course # 612-231-15 / 1.0 credit hours
Karen L. Swartz, MD Associate Professor of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine Director, Mood Disorders Clinical Programs Director, Adolescent Depression Awareness Johns Hopkins Hospital
Level of Instruction: Basic Category: General Target Audience: All are welcome
Description: Being sad or upset is a normal part of life, but when are these feelings something more? This session will discuss the differences between typical feelings and the medical illness, major depression. Symptoms and treatment options of depression will also be reviewed. Objectives: At the completion of the presentation, the audience will be able to:
Discuss the symptoms of depression Identify current treatments of depression
14
Monday, November 2, 2015
3:30p-4:30p Room: Tilghman Auditorium
Microbes that Make You Mad
Course # 612-218-15 / 1.0 credit hours
Zina Meriden, MD Resident Physician, PGY4, Department of Psychiatry 2012 Graduate of AP/CP Residency, Department of Pathology Johns Hopkins University School of Medicine
Level of Instruction: Intermediate Category: Microbiology Target Audience: All are welcome
Description: Infection with various microbial pathogens may mimic a primary mental illness. Being able to draw this distinction has major implications for patient treatment. The purpose of this talk will be to present some of the more common pathogens which can underlie psychiatric disturbances, as well as the diagnosis and treatment of these organisms. Objectives: At the completion of the presentation, the audience will be able to:
Appreciate that infection with microbial pathogens can simulate an organic psychiatric illness
Describe the epidemiology, diagnosis, and treatment of several microorganisms that can cause psychiatric disturbances
15
Tuesday, November 3, 2015
8a-3:30p: Registration (Turner Concourse)
8:30a-9:30a Room: TBA
Phlebotomy “Hot” Topics: Ergonomics; Pediatrics; Blood
Cultures
Course # 612-233-15 / 1.0 credit hours
Mark Sobota, BS, CSP Industrial Hygienist, Johns Hopkins Health Safety and Environment Johns Hopkins Hospital
Charles Anderson Jr., PBT(ASCP) Adjunct Instructor, CCBC Venipuncture Program PACE Business Analyst, Johns Hopkins HealthCare
Reginald Taylor, BS, M(ASCP)CM
Clinical Lab Scientist III, Clinical Microbiology Division Department of Pathology, The Johns Hopkins Hospital
Level of Instruction: Basic Category: Phlebotomy/Quality Assurance Target Audience: All are welcome
Description: This session will include three important topics for phlebotomists and their co-workers in the laboratory. Focusing first on the precious phlebotomists themselves, a safety specialist will encourage the team to engage in ergonomic practices every day to stay healthy. Next, we will turn our focus to our precious pediatric patients by reviewing anatomy and physiology and proper blood collection techniques. Lastly, we will focus on precious blood culture collections by reviewing their impact in patient care, the importance of following procedure, and the insights gained from quality monitoring. Objectives: At the completion of the presentation, the audience will be able to:
Describe ways to protect against self-injury while performing phlebotomy
Distinguish performing phlebotomy on pediatric patients from other age groups
Recognize the importance of blood cultures in patient care and the need for proper collection
Explain at least three unique and specialized duties phlebotomists perform as part of the patient care team
16
Tuesday, November 3, 2015 8:30a-9:30a Room: TBA
A Lung Mass: What Could It Be?
Course # 612-220-15 / 1.0 credit hours
Zahra Maleki, MD Assistant Professor of Pathology Division of Cytopathology Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Cytopathology Target Audience: All are welcome
Description: Lung masses have a very wide differential diagnosis. They can be a single mass or multiple masses, benign or malignant, primary or metastatic tumors. This presentation reviews the diagnostic procedures, differential diagnosis for lung mass or masses, ancillary tests, and molecular studies. Objectives: At the completion of the presentation, the audience will be able to:
Describe the diagnostic procedures utilized for lung masses
List most important clinical history and symptoms
Describe benign conditions that cause lung nodules
Describe the major primary lung cancers
Identify risk factors for lung cancer
17
Tuesday, November 3, 2015
9:45a-10:45a Room: TBA
From the Morgue to the Molecular Lab:
An Abbreviated History of Anatomic Pathology
Course # 612-205-15 / 1.0 credit hours
Lisa Rooper, MD Resident Physician, PGY4 Department of Pathology Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: General Anatomic Pathology (Histology & Cytopathology) Target Audience: All are welcome
Description: This presentation aims to provide an entertaining overview of the history of anatomic pathology. What did the public think of the earliest autopsies? Who was the first person to look at tissue under a microscope, and what did he see? What went wrong during the first frozen section performed at Johns Hopkins? Why did surgeons provide the original surgical pathological services? When did cytopathology become an accepted technique for diagnosis and screening? How did public scandals shape pathology practice? And how do new diagnostic technologies fit into these traditions? Learn the answer to these questions and more regarding the background of our field and our jobs. Objectives: At the completion of the presentation, the audience will be able to:
Explain how pathology became a unique medical specialty
Discuss the importance of Johns Hopkins in pathology history
Describe how public events shaped pathology practice today
18
Tuesday, November 3, 2015
9:45a-10:45a Room: TBA
Adventures of a Floating Laboratory: A Mercy Ship
Experience
Course # 612-230-15 / 1.0 credit hours
Amie Merriken, MLS (ASCP)CM Clinical Laboratory Scientist III, Clinical Microbiology Division The Johns Hopkins Hospital
Level of Instruction: Basic Category: General Target Audience: All are welcome
Description: Ever wonder what it would be like to work in a laboratory on the largest civilian hospital ship? Come join us for one medical laboratory scientist's eight-week experience on the Africa Mercy in Madagascar and discover the rewards and challenges of this adventure. Learn how the ship is run and how she worked alongside other healthcare professionals to help the Malagasy people. Objectives: At the completion of the presentation, the audience will be able to:
Describe the setting of the clinical lab, tests performed, and testing methods used on the ship
Explain the challenges encountered and solutions implemented in this unconventional setting
Describe some of the patients served and the rewards of serving on this mission
19
Tuesday, November 3, 2015
9:45a-10:45a Room: TBA
Quality Laboratory Practice: Pre-Analytical Phase of
Laboratory Testing
Course # 612-237-15 / 1.0 credit hours
Kathy Nucifora, MPH, MT(ASCP) Director of Accreditation COLA
Level of Instruction: Basic Category: Phlebotomy/Quality Assurance Target Audience: All are welcome
Description: This presentation will focus on those errors which can occur in the pre-analytic phase of the life cycle of a laboratory test and will include test ordering, patient identification, and specimen acquisition. Ideas and tools on avoiding these pitfalls will be discussed. Objectives: At the completion of the presentation, the audience will be able to:
Evaluate areas in pre-analytic phase of where errors are prone to occur
Discuss best practices to avoid these errors
20
Tuesday, November 3, 2015
11:00a-12:00p Room: TBA
New Syphilis Serology: A Paradigm Shift in
Syphilis Testing for the 21st Century
Course # 612-219-15 / 1.0 credit hours
Barbara Detrick, PhD Professor of Pathology Johns Hopkins University School of Medicine Immunology Director, Department of Pathology Johns Hopkins Hospital
Level of Instruction: Intermediate Category: Immunology Target Audience: All are welcome
Description: Infectious syphilis has re-emerged in the United States and worldwide. The presentations of syphilis, often described as “the great imitator,” can be varied and atypical. Thus, serology remains a critical component in the diagnosis of syphilis. This session will feature the fascinating history of syphilis, a review of the early testing system, and presentation of the modern, up-to date algorithm for syphilis. Even today, there is no single serological test to identify active disease. In 2011, the Immunology Laboratory at Johns Hopkins Hospital implemented the new reverse sequence algorithm for syphilis. This presentation will highlight the utility of this paradigm shift to the newer serological tests, and through interesting cases, share our experience over the past four years. Objectives: At the completion of the presentation, the audience will be able to:
Discuss the utility of the new reverse syphilis algorithm
Compare the advantages of the new reverse syphilis algorithm to the traditional syphilis algorithm
List and describe the methods used in the reverse syphilis algorithm
21
Tuesday, November 3, 2015
11:00a-11:30a Room: TBA (30 minute)
Patent Medicine: Selling The Cure
Course # 612-207-15 / 0.5 credit hours
Norm Barker, MS, MA, RBP Professor of Pathology & Art as Applied to Medicine Johns Hopkins University School of Medicine
Michael Torbenson, MD Professor of Pathology Mayo Clinic Rochester, Minnesota
Level of Instruction: Basic Category: General Target Audience: All are welcome
Description: This presentation of trade card images explores several major themes used in the advertising of patent medicines. These advertising themes are of historical importance because they document and illuminate one of the most critical time periods in the history of Western medicine: the transition from ancient Galenic notions of internal humors as a cause of disease, to modern understandings that both internal and external factors, such as microorganisms, can cause disease. Objectives: At the completion of the presentation, the audience will be able to:
Appreciate a historical perspective on the patent medicine industry at the turn of the 19th century before the government started to regulate ingredients
Describe how the newly invented art form of chromolithography which brought color to millions affected printed ephemera and the patent medicine trade
22
Tuesday, November 3, 2015
1:00p-2:00p Room: TBA
The Value of Postmortem Microbiology Cultures
Course # 612-204-15 / 1.0 credit hours
Stefan Riedel, MD, PhD, D(ABMM), FCAP Associate Professor of Pathology Johns Hopkins University School of Medicine Director, Clinical Pathology Laboratories Johns Hopkins Bayview Medical Center
Level of Instruction: Intermediate Category: Microbiology, Quality Assurance, Autopsy Target Audience: All are welcome
Description: The utility of postmortem microbiologic examinations has been
a topic of controversy ever since the inception of evidence-based scientific concepts in medicine in the 19th century. Numerous published studies describe a lack of correlation between antemortem clinical and laboratory
findings and postmortem culture results. However, there is equal evidence from other studies that indicates at least one limited utility of postmortem
microbiologic examinations in select cases. In the past, autopsies and postmortem microbiologic examinations have contributed to the discovery of novel infectious microorganisms. However, the problems of implementing routine procedures in daily autopsy practice related to the lack of consensus on the broader utility, as well as a lack of regulatory guidelines, have also been well appreciated. This presentation provides an overview of the utility of postmortem microbiologic examinations, together with some practical aspects and guidelines for those confronted with making the decision to allow or discourage the use of bacteriologic cultures obtained during autopsies. Objectives: At the completion of the presentation, the audience will be able to:
Describe the potential concerns regarding the postmortem spread of microorganisms
Describe the methods for specimen procurement for postmortem microbiology cultures
Identify the limitations of postmortem microbiology cultures and examinations
23
Tuesday, November 3, 2015
1:00p-2:00p Room: TBA
Get Computer Security Savvy - Answers to Questions
You Didn’t Know You Had
Course # 612-221-15 / 1.0 credit hours
Alan O’Neill, B.S. and Pathology Data Systems Staff Pathology Data Systems The Johns Hopkins Hospital
Level of Instruction: Basic Category: Computer/IT Target Audience: All are welcome
Description: With each passing day, cybersecurity becomes more critical. Threats to your computer can sneak in and cause serious damage if you are not aware of what to look for. In this program, you will learn to become mindful of potential security threats to your work and home computers that use the Windows operating system, and you will increase your awareness of possible dangers that can be avoided. The program will also give tips to help you make more informed decisions and implement better security practices. Objectives: At the completion of the presentation, the audience will be able to:
Utilize better security practices while operating work and home Windows computers
Recognize potential security threats and understand reasonable courses of action
Identify possible risks when connecting to public Wi-Fi
Describe the importance of maintaining Windows updates and application updates
24
Tuesday, November 3, 2015
2:15p-3:15p Room: TBA
Parasite Look-Alikes: Do You Know One When You
See One?
Course # 612-208-15 / 1.0 credit hours
Patricia (Trish) J. Simner, PhD, D(ABMM) Assistant Professor of Pathology and Medicine Johns Hopkins University School of Medicine Director of Medical Parasitology Johns Hopkins Hospital
Level of Instruction: Intermediate Category: Microbiology Target Audience: All are welcome
Description: This will be a fun interactive case-based session describing parasite look-alikes submitted to the Johns Hopkins Parasitology Laboratory. A few "true" parasite cases will be thrown in to keep the audience on their feet. Objectives: At the completion of the presentation, the audience will be able to:
Differentiate true parasites from parasite look-alikes encountered in the parasitology laboratory
Describe the basic epidemiology and laboratory testing required for identification of parasites in the clinical laboratory
25
Tuesday, November 3, 2015
2:15p-3:15p Room: TBA
Interventions to Alter Testing Behavior: How
to Manage Questionable Orders and
Mishandled Specimens without Making
Everybody Hate You Course # 612-212-15 / 1.0 credit hours
Jennifer Bynum, MD Resident Physician, PGY3 Department of Pathology Johns Hopkins Medicine
Level of Instruction: Basic Category: Quality Assurance/Safety Target Audience: All are welcome
Description: We all have occasional unpleasant conversations with our colleagues about inappropriately ordered tests and/or inappropriately handled specimens. Many of these problems can be systematically addressed, and we will discuss different approaches to behavioral change, specific strategies for implementing change, and specific strategies for dealing with disagreement both before and after changes are made. Objectives: At the completion of the presentation, the audience will be able to:
Identify the advantages and disadvantages of passive, active, and multifaceted approaches to changing behavior
Review strategies for implementing change and understand the data that supports what works best
Describe strategies for approaching and dealing with disagreement among those impacted by implemented changes
26
Tuesday, November 3, 2015
3:30p-4:30p Room: Tilghman Auditorium
Blood Transfusion: The History of a Life-Saving
Technology
Course # 612-223-15 / 1.0 credit hours
Peter Miller, MD Transfusion Medicine Fellow Department of Pathology Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Blood Bank Target Audience: All are welcome
Description: Sometimes to understand where we are, we need to see how far we have come. Blood transfusions have been possible for almost 200 years. About 15 million units of blood are donated each year in the United States. Although the first successful human blood transfusion was performed in 1818, it was not until 1901 when the first human blood groups were discovered that blood transfusion became a reality. From discoveries of other blood antigens to better knowledge of antibody production, this technology has progressed to what millions of patients depend on as life-saving. The inspiring and sometimes tragic history of blood transfusion helps us appreciate this technology and theorize about what is possible in the future. Objectives: At the completion of the presentation, the audience will be able to:
Describe the major milestones in the history of blood transfusion technology development
Identify the key factors and scientists which influenced the development of blood transfusion technology
Define the basic concepts of incompatibility and antibody production as they apply to blood transfusion
Discuss several of the future research goals in transfusion medicine
27
Wednesday, November 4, 2015
8a-3:30p: Registration (Turner Concourse)
8:30a-9:30a Room: TBA
William Henry Welch and the Transformation of
Medicine in America Course # 612-214-15 / 1.0 credit hours
Ralph H. Hruban, MD Baxley Professor and Director of Pathology Professor of Oncology Johns Hopkins University School of Medicine Pathologist-in-Chief Johns Hopkins Hospital Director, Sol Goldman Pancreatic Research Center Johns Hopkins Medicine
Level of Instruction: Basic Category: General Target Audience: All are welcome
Description: Dr. William Henry Welch was the first director of the Department of Pathology here in the Johns Hopkins University School of Medicine. Dr. Welch fundamentally transformed American Medicine from a primitive practice learned through the apprentice system, to a science-based field thought through rigorous scientific training. In this talk we will trace the remarkable life story of our first director. Objectives: At the completion of the presentation, the audience will be able to:
Describe one of the major changes that the Johns Hopkins University School of Medicine brought to American Medicine
Explain how William Henry Welch played a central role in setting the direction for the Johns Hopkins University School of Medicine
Name the four doctors in the famous John Singer Sargent painting of “The Four Doctors”
28
Wednesday, November 4, 2015
8:30a-9:30a Room: TBA
Tumor Immunology and the Development of
Companion Diagnostic Tests for Anatomic Pathology
Course # 612-234-15 / 1.0 credit hours
Stella Redpath, PhD Leader for Medical and Scientific Affairs Roche Tissue Diagnostics
Level of Instruction: Intermediate Category: Immunology/ Surgical Pathology/ Molecular Target Audience: Technologists, Leads, Physicians
Description: Cancer involves cellular changes. Some of these changes help tumors escape immune detection. Finding these proteins, such as PD-L1 and PD-1, and developing drugs that target them can undo this process, allowing the patient's immune system to fight again. Development of companion diagnostic tests using immunohistochemistry to detect the expression of PD-L1 markers in cancer marks a new and exciting future for the role of anatomic pathology in personalized healthcare. Objectives: At the completion of the presentation, the audience will be able to:
Identify the theory of cancer development
Describe the relationship between immunological response and cancer cellular changes
Appreciate the role of targeted drugs in personalized cancer treatment
29
Wednesday, November 4, 2015
9:45a-10:45a Room: TBA
Pharmacogenetics: Are Your Drug-Metabolizing
Enzymes Fast or Slow?
Course # 612-222-15 / 1.0 credit hours
Allison Chambliss, PhD Clinical Chemistry Fellow Department of Pathology Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Clinical Chemistry/Molecular Target Audience: All are welcome
Description: Appropriate dosing of pharmaceuticals is critical to prevent sub-therapeutic efficacy or the occurrence of adverse events. However, genetic variability may significantly influence an individual’s response to a therapeutic agent. Wide genetic variability has been observed in a number of drug-metabolizing enzymes which are responsible for the activation or inactivation of numerous drug classes. Targeted identification of specific genetic variants may assist in providing the optimal drug at the optimal dose to the correct patient. With the aid of case studies, this presentation will describe representative genetic variants that are known to influence the metabolism of commonly-prescribed medications. The presentation will also explore the current analytical platforms and challenges associated with implementing pharmacogenetic testing in a clinical laboratory environment. Objectives: At the completion of the presentation, the audience will be able to:
Describe the role of genetics in the metabolism of commonly-prescribed medications
Relate genotypes of frequent drug-metabolizing variants to drug activity
Discuss the advantages and disadvantages of current approaches to pharmacogenetic testing
30
Wednesday, November 4, 2015
9:45a-10:45a Room: TBA
Positively Pathology - Are You Passing It On?
Course # 612-217-15 / 1.0 credit hours
Doris Pendergrass, SPHR, SHRM-SCP Human Resources Director Department of Pathology Johns Hopkins Medicine
Level of Instruction: Basic Category: General Target Audience: All are welcome
Description: No matter what your title or location, Positively Pathology starts with you! We all want to work in a positive work environment. We all want the Department to have a well-respected and positive reputation across all of Johns Hopkins Medicine and in the communities we serve. How do we each play a role in that and what can you as an individual do to contribute? Objectives: At the completion of the presentation, the audience will be able to:
Generate realistic ideas for how to personally be a part of improving civility, kindness, and creating a positive work environment
Practice a few techniques for keeping yourself positive and upbeat, even on hectic or stressful days
31
Wednesday, November 4, 2015
11:00a-12:00p Room: TBA
Blood Collection and Component Manufacturing Course # 612-224-15 / 1.0 credit hours
P. Dayand Borge, Jr., MD, PhD Medical Director, Eastern Division American Red Cross
Level of Instruction: Basic Category: Blood Bank Target Audience: All are welcome
Description: Ever wonder where the blood components in the blood bank come from? How donors are selected, blood collected, and manufactured into the products that are issued to patients? Please join us for a presentation from one of our blood suppliers. Objectives: At the completion of the presentation, the audience will be able to:
Discuss the current state of blood donor recruitment and the issues faced when targeting specific types of donors
Describe the manufacturing process for preparing red blood cells, platelets, plasma, and cryoprecipitate for transfusion
32
Wednesday, November 4, 2015
11:00a-12:00p Room: TBA
Lab "Errors": A Practical Guide to Investigation in
the Clinical Lab Course # 612-226-15 / 1.0 credit hours
Deborah S. Williams, BA, MT(ASCP) Quality Assurance Specialist Department of Pathology CQI Office Community Division, Suburban Hospital
Level of Instruction: Intermediate Category: Quality Assurance Target Audience: Technologists, Leads, Supervisors, Managers
Description: “What happened and how do I figure out why?” This presentation will be an overview of the different types of errors/ variances that may occur in the Laboratory from patient testing to laboratory practice and quality assurance. The investigation process will be broken down into basic, general components that can be applied to any failure, error or deviation from a process, to determine what happened and how. Through the use of examples the investigation components will be demonstrated. This presentation will be particularly useful for the bench tech who troubleshoots QC failures to the QA specialist who investigates CAP proficiency failures or patient care issues. Objectives: At the completion of the presentation, the audience will be able to:
Define categories of "Errors/Variances" that occur in the Clinical Lab
Define basic components of any investigation process
Demonstrate basic investigation techniques
Apply basics of investigation to each error category
33
Wednesday, November 4, 2015
1:00p-2:00p Room: TBA
Advances in Antithrombotic Therapy Monitoring
Course # 612-211-15 / 1.0 credit hours
Thomas S. Kickler, MD Professor of Pathology, Medicine, and Oncology Johns Hopkins University School of Medicine Director, Hematology and Coagulation Laboratories Johns Hopkins Hospital
Level of Instruction: Intermediate Category: Hematology Target Audience: All are welcome (especially technologists, leads, nurses, and physicians)
Description: Review the general pharmacology of anticoagulants and discuss the therapeutic monitoring of both antiplatelet drugs and anticoagulants. Objectives: At the completion of the presentation, the audience will be able to:
Explain the pharmacology of warfarin and heparin so that one may better understand the monitoring of these agents, as well as the new target-specific agents
Describe the principles of coagulation testing using clot-based and chromogenic assays
Identify the tests used in monitoring antiplatelet agents
34
Wednesday, November 4, 2015
1:00p-2:00p Room: TBA
Laboratory Management and Laboratory
Leadership: Why We Need Both
Course # 612-235-15 / 1.0 credit hours
Allen Valentine, MBA, C(ASCP) Administrator, Department of Pathology Administrative Director, Johns Hopkins Medical Laboratories Johns Hopkins Medicine
Level of Instruction: Intermediate Category: Hematology Target Audience: Leads/Supervisors/Managers
Description: As laboratorians, we are natural managers due to the regulatory standards and our scientific responsibilities. However, we often need to be reminded that we need to utilize leadership skills to motivate our teams. It is the perfect balance of management and leadership that results in great outcomes. Objectives: At the completion of the presentation, the audience will be able to:
Identify the difference between managerial and leadership skills
Determine when to utilize management traits versus leadership skills
Identify Pathology outcomes where there was an emphasis of
management skills or leadership skills or both
35
Wednesday, November 4, 2015
2:15p-3:15p Room: TBA
Autoimmune Hemolytic Anemia: Diagnosis, Drugs,
and Transfusion
Course # 612-210-15 / 1.0 credit hours
Paul M. Ness, MD Professor of Pathology and Oncology Johns Hopkins University School of Medicine Director, Division of Transfusion Medicine Johns Hopkins Hospital
Level of Instruction: Advanced Category: Blood Bank Target Audience: All are welcome (especially technologists, leads, nurses, and physicians)
Description: The Transfusion Service prides itself on providing crossmatch-compatible blood for patients in need of a red blood cell (RBC) transfusion, but what do you do in the case of autoimmune hemolytic anemia? This talk will review clinical and laboratory diagnosis of the two most common types of autoimmune hemolytic anemia and how to manage them even when crossmatch-compatible blood is not available. Objectives: At the completion of the presentation, the audience will be able to:
Identify two types of autoimmune hemolytic anemia based on clinical and laboratory findings
Recommend treatment and transfusion options for patients with autoimmune hemolytic anemia
Explain the laboratory’s role in selecting donor units for patients with warm autoimmune hemolytic anemia
36
Wednesday, November 4, 2015
2:15p-3:15p Room: TBA
Separating the Wheat from the Chaff: What is Celiac
Disease and Gluten Sensitivity?
Course # 612-227-15 / 1.0 credit hours
Whitney M. Green, MD Fellow, Gastrointestinal and Liver Pathology Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Immunology & Surgical Pathology Target Audience: All are welcome
Description: Celiac disease (aka gluten intolerance) is an autoimmune disorder that occurs in genetically predisposed individuals and is characterized by an intestinal inflammatory response to gluten, a protein found in wheat and other related grains. In recent decades, the incidence of celiac disease has risen dramatically to suggest interplay of changes in various environmental factors in those who are susceptible. Moreover, while celiac disease is well-recognized manifestation of gluten sensitivity, there is a spectrum of disease that includes non-celiac gluten sensitivity which has a myriad of intestinal and extraintestinal manifestations. We will discuss the gluten, the pathophysiology of celiac disease, and its diagnosis and treatment, as well as the difference between celiac and non-celiac gluten sensitivity. Objectives: At the completion of the presentation, the audience will be able to:
Explain "What is gluten?"
Describe the pathophysiology, diagnosis, and treatment of celiac disease
Explain the difference between celiac disease and non-celiac gluten sensitivity
Describe the extraintestinal manifestations of gluten sensitivity
37
Wednesday, November 4, 2015
3:30a-4:30p Room: TBA
Cervical Cancer: From Henrietta Lacks to the HPV
Vaccine Course # 612-232-15 / 1.0 credit hours
Marissa White, MD Resident Physician, PGY3 Department of Pathology Johns Hopkins University School of Medicine
Level of Instruction: Basic Category: Cytopathology/ Surgical Pathology / Microbiology Target Audience: All are welcome
Description: Cervical cancer previously was a leading cause of female cancer-related deaths, particularly in women of childbearing age. With the introduction of cervical cancer screening, the death rate from cervical cancer has significantly decreased. Recent advances such as changes to cervical cancer screening practices and recommendations, and the introduction of routine human papillomavirus (HPV) vaccination aim to reduce the incidence of cervical cancer and further improve patient survival. This presentation will review the pathogenesis, basic cytology, and histology of cervical precancerous and cancerous lesions. Additionally, we will discuss the changes to cervical cancer screening practices and current recommendations for HPV vaccination. Objectives: At the completion of the presentation, the audience will be able to:
Identify the methods of HPV transmission
Discuss the basic cytology and histology of cervical precancerous and cancerous lesions
List the current recommendations for cervical cancer screening
Identify patient populations recommended by the CDC to get the HPV vaccine
38
Wednesday, November 4, 2015
3:30p-4:30p Room: Tilghman Auditorium
Tissue Donation for Transplantation: The People,
the Process, and the Success of Dermal Grafts
for Post-Mastectomy Breast Reconstruction
Course # 612-236-15 / 1.0 credit hours
Rick Kolovich, RN, CPTC, CCTC, CTBS Clinical Manager Donor Services Living Legacy Foundation
Heather Brennan, PhD Director, Marketing Musculoskeletal Transplant Foundation
Lauralee Brown, RN, MHSA, CPHQ Regional Director Musculoskeletal Transplant Foundation
Level of Instruction: Basic Category: General/Blood Bank Target Audience: All are welcome
Description: The gift of musculoskeletal tissue (bone/skin) donation after death has a profound effect on thousands of recipients annually. The gift of dermal (skin) tissue provides surgical patients with grafts to rebuild the breast wall post-mastectomy from breast cancer following breast reconstruction. The gift additionally assists the donor family as they seek to find solace and a positive outcome from the loss of their loved one. Musculoskeletal donation is a win-win for so many. This presentation will discuss the referral/recovery process and dermal utilization at Johns Hopkins Medicine.
Objectives: At the completion of the presentation, the audience will be able to:
Describe the Living Legacy Foundation (LLF) tissue donation process, from donor referral to recovery
Describe the significance of dermal tissue for post-mastectomy breast reconstruction
39
Third Annual Pathology
Educational Symposium Schedule at a Glance
Color Key:
General Chemistry Computer
Surgical Pathology Hematology Molecular
Blood Bank Microbiology Quality Assurance
Cytology Immunology Phlebotomy
Pathology Symposium Committee
Chairs: Barbara Parsons & Lorraine Blagg
Barbara Detrick Marian Turpin Christine Hostetter Mayer Rubin
Debbie Williams Monica Gray Doris Pendergrass Nancy Nath
Eunhee Rim Paula Mister Jo Shim Renata Karlos Karen Bordenet Rosemary Hines Kelly Baloga Suzy Nicol Kurt Michael Tammy Heacock Linda Gluck Vanessa Rodas-Eral Maria Barata
40
Lun
ch
(Turn
er C
on
co
urse
)
Ro
om
#3
Ro
om
#2
Ro
om
#1
Turn
er A
ud
itoriu
m
Re
gistra
tion
(Low
er Tu
rne
r Co
nc
ou
rse)
Mo
nd
ay
No
ve
mb
er 2
, 20
15
Re
gistra
tion
8a
-3:3
0p
8:0
0
AM
Taking
Qu
ality to
the N
ext Level
8:3
0
AM
Snakes, Sn
ake
Hu
ntin
g an
d th
e
Path
op
hysio
l. o
f a Snakeb
ite
Up
date o
n
Hep
atitis C:
The En
d o
f th
e Begin
nin
g
10
:00
AM
Cu
lture o
f Safety in
the
Lab
Urin
e For a
Go
od
Talk: Wh
y U
rinary Tract
Cyto
path
olo
gy Is P
op
ular O
nce
Again
11
:15
AM
Lun
ch
12
:15
PM
The M
agic of
Au
to-SM
ILE
Sickle Cell
Disease
Weird
Micro
III: Th
e An
imal
Plan
et
1:0
0 P
M
Wh
en G
oo
d
Devices G
o
Bad
Difficu
lt or
Dep
ressed?
Reco
gnizin
g D
epressio
n
2:1
5 P
M
Micro
bes
That
Make Yo
u
Mad
3:3
0 P
M
Se
co
nd
An
nu
al P
ath
olo
gy
Ed
uc
atio
na
l Sy
mp
osiu
m
Sc
he
du
le a
t a G
lan
ce
Third
An
nu
al P
ath
olo
gy
Ed
uc
atio
na
l Sy
mp
osiu
m
Sc
he
du
le a
t a G
lan
ce
41
Lun
ch
(Turn
er C
on
co
urse
)
Ro
om
#3
Ro
om
#2
Ro
om
#1
Re
gistra
tion
(Lo
we
r Turn
er C
on
co
urse
)
Tue
sda
y
No
ve
mb
er 3
, 20
15
Re
gistra
tion
8a
-3:3
0p
8:0
0
AM
A Lu
ng
Ma
ss:
Wh
at C
ou
ld
It Be
?
Ph
leb
oto
my
“H
ot” To
pic
s
8:3
0 A
M
Qu
ality
Lab
Pra
ctic
e:
Pre
-
An
aly
tica
l
Ph
ase
Ad
ve
ntu
res
of a
Flo
atin
g
Lab
ora
tory
: A
Me
rcy S
hip
Exp
erie
nc
e
Fro
m th
e
Mo
rgu
e to
the
Mo
lec
ula
r
Lab
:
9:4
5 A
M
Ne
w
Syp
hilis
Se
rolo
gy:
A
Pa
rad
igm
Sh
ift
Pa
ten
t
Me
dic
ine
:
Se
lling
The
Cu
re
(30 M
in)
11
:00
AM
Lun
ch
12
:00
PM
Ge
t
Co
mp
ute
r
Se
cu
rity
Sa
vvy
The
Va
lue
of
Po
stmo
rtem
Mic
ro
Cu
lture
s
1:0
0 P
M
Inte
rve
ntio
ns
to A
lter
Testin
g
Be
ha
vio
r
Pa
rasite
Loo
k-A
like
s:
Do
Yo
u
Kn
ow
On
e
Wh
en
Yo
u
Se
e O
ne
?
2:1
5 P
M
Blo
od
Tran
sfusio
n,
The
Histo
ry
of a
Life-
Sa
vin
g
Tec
hn
olo
gy
3:3
0 P
M
Third
An
nu
al P
ath
olo
gy
Ed
uc
atio
na
l Sy
mp
osiu
m
Sc
he
du
le a
t a G
lan
ce
42
Lun
ch
(Turn
er C
on
co
urse
)
Ro
om
#3
Ro
om
#2
Ro
om
#1
Re
gistra
tion
(Lo
we
r Turn
er C
on
co
urse
)
We
dn
esd
ay
N
ov
em
be
r 4, 2
01
5
Re
gistra
tion
8a
-3:3
0p
8:0
0
AM
Tum
or
Imm
un
olo
gy
& A
na
tom
ic
Pa
tho
log
y
Willia
m H
en
ry
We
lch
an
d th
e
Tran
sform
atio
n
of M
ed
icin
e in
Am
eric
a
8:3
0 A
M
Po
sitive
ly
Pa
tho
log
y:
Are
Yo
u
Pa
ssing
It On
?
Ph
arm
ac
o-
ge
ne
tics:
9:4
5 A
M
Blo
od
Co
llec
tion
&
Co
mp
on
en
t
Ma
nu
fac
tur-
ing
Lab
Erro
rs:
11
:00
AM
Lun
ch
12
:00
PM
Lab
Mg
mt.
an
d La
b
Lea
de
rship
Ad
va
nc
es
in A
nti-
Thro
mb
otic
The
rap
y
Mo
nito
ring
1:0
0 P
M
Se
pa
rat-
ing
the
Wh
ea
t
from
the
Ch
aff
Au
toim
mu
ne
He
mo
lytic
An
em
ia
Dia
gn
osis,
Dru
gs, a
nd
Tran
sfusio
n
2:1
5 P
M
Tissue
Do
na
tion
for
Po
st- M
aste
cto
my
Ce
rvic
al
Ca
nc
er:
Fro
m
He
nrie
tta
Lac
ks to
the
HP
V
Va
cc
ine
3:3
0 P
M
Third
An
nu
al P
ath
olo
gy
Ed
uc
atio
na
l Sy
mp
osiu
m
Sc
he
du
le a
t a G
lan
ce
43
REGISTRATION
Name: ______________________________ Badge #:___________________ Email: _________________________________________________________ JHM Entity: __________________ Division: ___________________________ Supervisor/Manager: _____________________________________________
Selection for the Sessions: Employee: This is a preliminary schedule and is subject to change. To aid us in planning and assigning rooms for each talk, please register at
http://pathology.jhu.edu/department/training/symposium.cfm You must also register for lunch if you wish to have a lunch available to you only on days you are attending. Registration deadline is October 15, 2015. You may be required to get Supervisor approval before registering.
Are you interested in Volunteering for this event? http://vols.pt/eb8ujK Examples: Session Moderator, Registration, Room Lead, Lunch, etc.
MONDAY, NOVEMBER 2, 2015
Time Course
8:30-9:30a Taking Quality to the Next Level 612-202-15 10:00-11:00a Update on Hepatitis C 612-203-15 10:00-11:00a Snakes, Snake Hunting, and a Snakebite 612-215-15 11:15-12:15p Urine for a Good Talk 612-216-15 11:15-12:15p Culture of Safety in the Lab 612-225-15 12:15-12:45p Lunch 1:00-2:00p Weird Micro III: The Animal Planet 612-209-15 1:00-2:00p Sickle Cell Disease 612-229-15 1:00-2:00p The Magic of Auto-SMILE 612-206-15 2:15-3:15p When Good Devices Go Bad 612-228-15 2:15-3:15p Difficult or Depressed? 612-231-15 3:30-4:30p Microbes that Make You Mad 612-218-15 TUESDAY, NOVEMBER 3, 2015
Time Course
8:30-9:30a Phlebotomy “Hot” Topics 612-233-15 8:30-9:30a Lung Mass: What Could It Be? 612-220-15 9:45-10:45a From the Morgue to the Molecular Lab 612-205-15 9:45-10:45a Adventures of a Floating Laboratory 612-230-15 9:45-10:45a Quality Lab Practice: Pre-Analytical Phase 612-237-15
44
REGISTRATION (continued)
TUESDAY, NOVEMBER 3, 2015 (continued)
Time Course
11:00-11:30a Patent Medicine: Selling The Cure 612-207-15 11:00-12:00p New Syphilis Serology: A Paradigm Shift 612-219-15 12:00–12:45p Lunch 1:00-2:00p Value of Postmortem Microbiol. Cultures 612-204-15 1:00-2:00p Get Computer Security Savvy 612-221-15 2:15-3:15p Parasite Look-Alikes 612-208-15 2:15-3:15p Interventions to Alter Testing Behavior 612-212-15 3:30-4:30p Blood Transfusion, The History of 612-223-15
WEDNESDAY, NOVEMBER 4, 2015
Time Course
8:30-9:30a William Welch and Medicine in America 612-214-15 8:30-9:30a Tumor Immunology & Anatomic Pathology 612-234-15 9:45-10:45a Pharmacogenetics: Metabolization 612-222-15 9:45-10:45s Positively Pathology: Are You Passing It On 612-217-15 11:00-12:00p Blood Collection & Component Mfg. 612-224-15 11:00-12:00p Lab Errors 612-226-15 12:00–12:45p Lunch 1:00-2:00p Anti-Thrombotic Therapy Monitoring 612-211-15 1:00-2:00p Lab Management & Lab Leadership 612-235-15 2:15-3:15p Autoimmune Hemolytic Anemia 612-210-15 2:15-3:15p Separating the Wheat from the Chaff 612-227-15 3:30-4:30p Cervical Cancer 612-232-15 3:30-4:30p Tissue Donation for Post-Mastectomy 612-236-15